These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37591680)

  • 1. Development and Verification of Time-Series Deep Learning for Drug-Induced Liver Injury Detection in Patients Taking Angiotensin II Receptor Blockers: A Multicenter Distributed Research Network Approach.
    Heo S; Yu JY; Kang EA; Shin H; Ryu K; Kim C; Chegal Y; Jung H; Lee S; Park RW; Kim K; Hwangbo Y; Lee JH; Park YR
    Healthc Inform Res; 2023 Jul; 29(3):246-255. PubMed ID: 37591680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin Receptor Blockers and the Risk of Suspected Drug-Induced Liver Injury: A Retrospective Cohort Study Using Electronic Health Record-Based Common Data Model in South Korea.
    Kim H; Son N; Jeong D; Yoo M; Choi IY; Choi W; Chung YW; Ko SW; Byun S; Im S; Sim DW; Seo J; Kang MG; Lee JK; Seo YG; An HJ; Kim Y; Chae S; Jun DW; Chang DJ; Kim SG; Yi S; Yang HJ; Lee I; Park HJ; Lee JH; Kim B; Lee EE
    Drug Saf; 2024 Jul; 47(7):673-686. PubMed ID: 38512445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study.
    Nishida Y; Takahashi Y; Susa N; Kanou N; Nakayama T; Asai S
    Cardiovasc Diabetol; 2013 Nov; 12():159. PubMed ID: 24180232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.
    Israili ZH
    J Hum Hypertens; 2000 Apr; 14 Suppl 1():S73-86. PubMed ID: 10854085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Antituberculosis Drug-Induced Liver Injury Using an Interpretable Machine Learning Method: Model Development and Validation Study.
    Zhong T; Zhuang Z; Dong X; Wong KH; Wong WT; Wang J; He D; Liu S
    JMIR Med Inform; 2021 Jul; 9(7):e29226. PubMed ID: 34283036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals.
    ARB Trialists Collaboration
    J Hypertens; 2011 Apr; 29(4):623-35. PubMed ID: 21358417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study.
    Eworuke E; Shinde M; Hou L; Paterson MJ; Jensen PB; Maro JC; Rai A; Scarnecchia D; Pennap D; Woronow D; Ghosh RE; Welburn S; Pottegard A; Platt RW; Lee H; Bradley MC
    BMJ Open; 2023 Apr; 13(4):e070985. PubMed ID: 37068898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photosensitivity with Angiotensin II Receptor Blockers: A Retrospective Study Using Data from VigiBase(®).
    Viola E; Coggiola Pittoni A; Drahos A; Moretti U; Conforti A
    Drug Saf; 2015 Oct; 38(10):889-94. PubMed ID: 26187686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R; Michailidis P
    Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telmisartan is the most effective ARB to increase adiponectin via PPARα in adipocytes.
    Hattori N; Yamada A; Nakatsuji S; Matsuda T; Nishiyama N; Shimatsu A
    J Mol Endocrinol; 2022 May; 69(1):259-268. PubMed ID: 35354667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitro.
    Zakrocka I; Targowska-Duda KM; Wnorowski A; Kocki T; Jóźwiak K; Turski WA
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Feb; 392(2):209-217. PubMed ID: 30370429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of angiotensin receptor blocker monotherapy in patients with hypertension in the Netherlands: a comparative analysis using clinical trial and drug utilization data.
    Boersma C; Voors AA; Visser ST; de Jong-van den Berg LT; Postma MJ
    Am J Cardiovasc Drugs; 2010; 10(1):49-54. PubMed ID: 20104934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review.
    Kamal A; Fain C; Park A; Wang P; Gonzalez-Velez E; Leffler DA; Hutfless SM
    Gastroenterol Rep (Oxf); 2019 Jun; 7(3):162-167. PubMed ID: 31217979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II receptor blockers for the treatment of heart failure: a class effect?
    Hudson M; Humphries K; Tu JV; Behlouli H; Sheppard R; Pilote L
    Pharmacotherapy; 2007 Apr; 27(4):526-34. PubMed ID: 17381379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of angiotensin-receptor blockers for preventing macrovascular disease in patients with diabetes: a population-based cohort study.
    Antoniou T; Camacho X; Yao Z; Gomes T; Juurlink DN; Mamdani MM
    CMAJ; 2013 Sep; 185(12):1035-41. PubMed ID: 23836857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and Pattern of Aminotransferase Elevation During Anti-Hypertensive Therapy With Angiotensin-II Receptor Blockers.
    Choi WJ; Kim GA; Park J; Jang S; Jung WJ; Shim JJ; Park Y; Choi GH; Kim JW; Jeong SH; Jang ES
    J Korean Med Sci; 2022 Aug; 37(33):e255. PubMed ID: 35996932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effects of olmesartan compared with other angiotensin receptor blockers: a meta-analysis.
    Wang L; Zhao JW; Liu B; Shi D; Zou Z; Shi XY
    Am J Cardiovasc Drugs; 2012 Oct; 12(5):335-44. PubMed ID: 22920046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of the efficacy of angiotensin II receptor blockers for uric acid level change in asymptomatic hyperuricaemia.
    Kim HS; Kim H; Lee SH; Kim JH
    J Clin Pharm Ther; 2020 Dec; 45(6):1264-1270. PubMed ID: 32737930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valsartan vs. other angiotensin II receptor blockers in the treatment of hypertension: a meta-analytical approach.
    Nixon RM; Müller E; Lowy A; Falvey H
    Int J Clin Pract; 2009 May; 63(5):766-75. PubMed ID: 19392925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term mortality and cardiovascular events of seven angiotensin receptor blockers in hypertensive patients: Analysis of a national real-world database: A retrospective cohort study.
    Lee W; Kang J; Park JB; Seo WW; Lee SY; Lim WH; Jeon KH; Hwang IC; Kim HL
    Health Sci Rep; 2023 Feb; 6(2):e1056. PubMed ID: 36741853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.